(800) 391-6415

Information about Primary Pulmonary Hypertension and other forms of Severe Pulmonary Hypertension

PPH NEWS is an education-based resource site that provides information on the health issues surrounding Primary Pulmonary Hypertension (PPH), including what it is, the symptoms, diagnoses, and treatment options.

This website also provides resource to learn more about your legal rights and remedies if you or someone you know has developed PPH due to the use of diet drugs such as Fen Phen.

Pulmonary Hypertension Medication


An alternative therapy to the more invasive Flolan and Remodulin, Tracleer (bosentan) comes in tablet form and is taken orally. Learn More about Tracleer...


Approved by the FDA in 1995 for the treatment of PPH, Flolan, or epoprostenol, is extremely effective in opening up blood vessels in the lungs and throughout the body. Flolan is a form of a naturally occurring molecule in the human body called prostaglandin. Learn More about Flolan...


In addition to Flolan, a drug called Remodulin (also known as UT-15) has been developed for the treatment of Pulmonary Hypertension (PH). Remodulin is a synthetic, stable form of prostacyclin, a naturally occurring substance in the human body. Learn More about Remodulin...

As of January 3, 2002 the Nationwide Class Action Settlement Agreement with American Home Products received Final Judicial Approval. PPH Patients must take immediate action and file independent lawsuits to ensure the proper compensation is recovered.

Medications for Pulmonary Hypertension

Learn More about these medications used to treat Pulmonary Hypertension:

» Tracleer
» Remodulin
» Flolan

After a positive diagnosis of PH, doctors will focus on creating a management program, usually featuring one or more medications for Pulmonary Hypertension. Treatment often proceeds in stages, depending upon the patient's response to each of the possible medications for Pulmonary Hypertension. The initial phase focuses on identifying the degree to which the pulmonary arteries can be dilated using medications for Pulmonary Hypertension. The patient will be given known vasodilators such as inhalable nitric oxide or intravenous prostacyclin or adenosine.

Patients who experience a notable drop in pulmonary vascular resistance are given medications for Pulmonary Hypertension designed to control pulmonary pressure, such as oral calcium channel blockers and anticoagulants. If the fall in pressure is minimal, patients will be given these same medications for Pulmonary Hypertension, but in higher doses coupled with vasodilators. These patients may also be candidates for heart and lung transplants.

Medications for Pulmonary Hypertension that are classified as vasodilators include Flolan, Remodulin and Tracleer. Two of these medications for Pulmonary Hypertension—Flolan and Remodulin—are injected (Flolan is administered intravenously, Remodulin subcutaneously). Both of these medications for Pulmonary Hypertension require that the patient wear a pack of some kind that releases the drug into the patient's system according to a timer. The third of these medications for Pulmonary Hypertension, Tracleer, is available in tablet form to be taken orally.

The newest medications for Pulmonary Hypertension are extremely expensive, and focus on treating symptoms, rather than reversing the damaged blood vessels. Medications for Pulmonary Hypertension often carry a high risk of side effects, such as the risk of sepsis associated with the use of Flolan, or birth defects resulting from Tracleer. While improvements can be made in the medications for Pulmonary Hypertension, many patients are still relying on the chance for a lung transplant as their best hope for treatment.

Medications for Pulmonary Hypertension may extend the lifespan of a patient for a few years, but there is as yet no cure for Pulmonary Hypertension. If you or a loved one is taking medications for Pulmonary Hypertension due to the use of diet drugs such as Fen Phen, consult an attorney to learn more about your legal rights. Medications for Pulmonary Hypertension are extremely expensive, and the costs may be the responsibility of a diet drug manufacturer. In addition to the cost of medications for Pulmonary Hypertension, drug manufacturers may be made to compensate for lost wages, pain and suffering, reduced quality of life, and more.

Get a FREE Case Evaluation by contacting our lawyers today